NewsDesk @bactiman63 In the 19 facilities of the Metropolitan Health Region, the authorities report that they maintain supplies of the oral drug miltefosine for the treatment of leishmaniasis. “The...

By NewsDesk  @infectiousdiseasenews With the back-to-back lethal cases of the “brain-eating amoeba”, Naegleria fowleri this month–in California and North Carolina–I wanted to...

In this podcast, I look at what I believe are the top infectious disease stories of the last decade.   Related: Texas anthrax: A look at the 2019 outbreak Naegleria fowleri: The PAM protocol with...

By Robert Herriman  @infectiousdiseasenews Not only was Dec. 31, 2019 the end of the year, but it was also the end of the 2010s decade (Jan. 1, 2010-Dec. 31, 2019). In this post, I list what I believe...

In this podcast of a video interview from the 4th Annual Amoeba Summit hosted by the Jordan Smelski Foundation, I spoke to Pediatric Infectious Disease Specialist at All Children’s Hospital Johns...

In the summer of 2016, then 16-year-old Florida teen, Sebastian DeLeon wound up in a Orlando hospital diagnosed with primary amoebic meningoencephalitis (PAM) due to the parasite, Naegleria fowleri. In...

Cook Children’s Medical Center in Fort Worth, Texas became the first hospital in the nation in 2016 to house a life-saving investigational drug called miltefosine (trade name, Impavido) used to treat...

On this week’s Outbreak News This Week Radio Show, I had the opportunity to spend the whole hour discussing the three most commonly diagnosed free-living amoeba species that infect humans:  Naegleria...

Naegleria fowleri is a protozoan parasite , more specifically an amoeba. This lethal parasite is commonly referred to as the “brain eating amoeba” in mainstream media. It is generally considered a...

Orlando-based specialty pharmaceutical company, Profounda announced it has received the US Food and Drug Administration’s Orphan Drug Designation for the use of Impavido (miltefosine) to treat Granulomatous...